On Monday, Purple Biotech Ltd (NASDAQ:PPBT) reported the final results from the randomized Phase 2 study of its lead oncology ...

Ark Invest chief Cathie Wood is known for scooping up shares of innovators early in their growth stories and holding on for ...

ROTH MKM has recently resumed Fortress Biotech Inc (FBIO) stock to Buy rating, as announced on March 15, 2024, according to Finviz. Earlier, on August 4, 2022, Ladenburg Thalmann had initiated the ...

Shares of Purple Biotech ($PPBT) surged more than 45% on Monday morning, reaching their highest levels since early October.

The boost in stock value is primarily attributed to the company’s recent announcement of positive final results from a Phase 2 study of its lead oncology drug, CM24. This milestone positions Purple ...

As breakthroughs in biotechnology accelerate, the sector is primed for significant expansion. With emerging trends like gene ...

The FDA has rejected Applied Therapeutics’ attempt to win approval on the strength of a failed phase 3 trial, triggering a 75 ...

Daiwa Securities Group Inc. lowered its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 9.3% in the third quarter, ...

If you have $500, you should check out Vertex Pharmaceuticals ( VRTX 0.13%). Here's why this biotech stock is a great ...

Latest on LIXT: Exclusive BAC Article: LIXTE Biotechnology; Q1 Of 2025 LB-100 ASTS Data, Two Small Studies Funded By Big Pharma And Catalysts ...